For additional information, visit the NCI Grant Activity Codes/Mechanisms webpage.
For additional information, visit the NCI Grant Activity Codes/Mechanisms webpage.
For additional information, see NCI Grant Activity Codes/Mechanisms.
Quoted from the NCI Dictionary of Cancer Terms.
For additional information, visit the NCI Office of Cancer Centers webpage and the NCI Grant Activity Codes/Mechanisms webpage.
For additional information, visit the NCI Grant Activity Codes/Mechanisms webpage.
For additional information, visit the NCI Grant Activity Codes/Mechanisms website.
PAs may be used for any support mechanism other than construction awards. Unless otherwise specified in the PA, new applications (and associated renewal and revision applications) submitted in response to PAs are treated as investigator-initiated. PAs also are used to annually solicit applications for the SBIR and STTR programs. Those applications must be received by the dates specified in the PA.
Program Announcements (PA) are published in the NIH Guide for Grants and Contracts. Go to Program Announcements. Learn more about types of funding opportunity announcements.
Quoted form the NIH OER Glossary & Acronym List.
Quoted from Office of Federal Advisory Committee Policy (OFACP) "Overview of Federal Advisory Committees at the NIH".
Quoted from the NCI DCTD CDP Program for the Assessment of Clinical Cancer Tests (PACCT) webpage.
For additional information, visit the NCI Partnerships to Advance Cancer Health Equity (PACHE) webpage.
Quoted from NIH Policy Manual Chapter 6315-1.
Learn more about types of funding opportunity announcements.
Quoted from the NIH OER Glossary & Acronym List.
Learn more about types of funding opportunity announcements.
Quoted from the NIH OER Glossary & Acronym List.
Quoted from §2.101 of the Federal Acquisition Regulation.
For additional information, visit the Pediatric Brain Tumor Consortium website.
Quoted from the NIH OER Glossary & Acronym List.
For additional information, visit the NIH OER PECASE webpage.
Quoted from the NCI Dictionary of Cancer Terms.
-Administration for Children and Families (ACF);
-Administration on Aging (AoA);
-Agency for Healthcare Research and Quality (AHRQ);
-Agency for Toxic Substances and Disease Registry (ATSDR);
-Centers for Disease Control and Prevention (CDC);
-Centers for Medicare & Medicaid Services (CMS);
-Federal Occupational Health (FOH);
-Food and Drug Administration (FDA);
-Health Resources and Services Administration (HRSA);
-Indian health Service (HIS);
-National Institutes of Health (NIH);
-Substance Abuse and Mental Health Services Administration (SAMHSA); and
-Public Health Service Commissioned Corps.
The central mission of the PHS is to protect the health of the country's population.
Quoted from the Federal Register.
The use of the eRA Commons xTrain system is mandatory to electronically prepare and submit PHS 2271 Statement of Appointment forms.
Quoted from the NIH OER Forms Library Manage Fellows and Trainees webpage.
NIH requires use of the Research Performance Progress Report (RPPR) for ALL Type 5 (non-competing continuation) annual progress reports. NIH use of the PHS 2590 is restricted to progress reports for administrative extensions (Type 4s; e.g., SBIR/STTR Fast-Track Phase II application).
For additional information, visit the Non-Competing Continuation Progress Report webpage.
Quoted from the NIH OER Glossary & Acronym List.
Non-Exclusive Patent Licenses grant to the licensee the nonexclusive right to make, use, and sell the technology for commercial purposes. The license is for the life of the last-to-expire patent rights and allows a company to commercialize a technology on a non-exclusive basis. Some companies find that an exclusive license agreement is not required to successfully develop and market technologies, such as diagnostic and prognostic technologies and imaging agents.
Visit the NCI Technology Transfer Center website for additional information.
Quoted from the NIH OER Glossary & Acronym List.
Quoted from the NIH OER Glossary & Acronym LIst.
Quoted from the NIH OER Glossary & Acronym List.
Quoted from the NIH OER Glossary & Acronym List.
NCI addressed unequal patterns of standard health care access through CRCHD's multisite Patient Navigation Research Program (PNRP). The PNRP focused on developing and testing interventions for follow-up and treatment initiation of four cancers with significant disparity: breast, cervical, prostate, and colorectal.
Although anyone could benefit from patient navigation services, the primary participants for this research program were populations experiencing cancer health disparities. These encompass racial/ethnic minorities, individuals with lower socioeconomic status, and residents of rural areas across the U.S.
PNRP grantees conducted formal qualitative and quantitative program evaluations to measure efficacy and cost-effectiveness of interventions and made recommendations for improving access to health care among health disparity populations.
For addition information, visit the NCI Center to Reduce Cancer Health Disparities (CRCHD), Disparities Research, Patient Navigation Research Program (PNRP) webpage.
Quoted from the NIH OER Glossary & Acronym List.
For additional information, visit the NIH OER Managing Conflict of Interest in NIH Peer Review of Grants and Contracts webpage.
Quoted from §300-3.1 of the Federal Travel Regulation.
The focus of the PRMS is on scientific merit, priorities, and progress of the clinical protocol research of the center. The PRMS should have the authority to open protocols that meet the scientific merit and scientific priorities of the center and to terminate protocols that do not demonstrate scientific progress.
For additional information, see the Current Cancer Center Support Grants (CSSGs) Program Announcement.
For additional information, visit the HealthMeasures' PROMIS webpage.
Quoted from Grants.Gov Grant Terminology.